Skyline Pharmaceuticals, Inc.

Fort Lauderdale, FL Doing business as Skyline Marketing

UEI
KGLTH91BDFE4
CAGE
97MF1
Primary NAICS
425120 Wholesale Trade Agents and Brokers
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
  • Small Business Joint Venture
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3323 W Commercial Blvd #125E, Fort Lauderdale, FL 33309, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 -$2,830
FY2024 $198,382

Contract awards

Similar vendors

About the company

Skyline Pharmaceuticals, Inc. is a for-profit small business joint venture and Subchapter S Corporation registered in the System for Award Management (SAM.gov) to receive federal contract awards. The company specializes in pharmaceutical product procurement and distribution, with a primary focus on supplying pharmaceutical products to federal agencies, particularly the Department of Veterans Affairs (VA). Registered since November 23, 2021, with a current registration valid until April 15, 2025, the company has positioned itself as a small business capable of providing targeted pharmaceutical solutions to government healthcare systems.

Over the past year, Skyline Pharmaceuticals, Inc. has been awarded multiple purchase order contracts from the VA's Veterans Integrated Service Network 15, consistently supplying a diverse range of pharmaceutical products to Consolidated Mail Outpatient Pharmacy (CMOP) facilities. These contracts, ranging in value from $21,430.02 to $140,076.00, have involved delivering specific pharmaceutical line items such as Saxagliptin HCL tablets, Sumatriptan injection kits, Sulfacetamide/Sulfur topical foam, Sodium Chloride inhalation solution, and Dorzolamide/Timolol ophthalmic solution. Most of these contracts were set aside for small businesses, demonstrating the company's ability to compete effectively in federal procurement processes. The contracts have typically had short performance periods, often between one to two months, and have been competitively awarded or specifically designated for small business participation, highlighting Skyline Pharmaceuticals' niche in providing targeted, efficient pharmaceutical procurement services to federal healthcare systems.

Quick answers

Is Skyline Pharmaceuticals, Inc. registered in SAM.gov?

Yes. Skyline Pharmaceuticals, Inc.'s SAM.gov registration is active through August 31, 2027.

How much has Skyline Pharmaceuticals, Inc. received in federal contracts?

Federal contracts obligated $195,552 to Skyline Pharmaceuticals, Inc. in fiscal years 2023 through 2027.

What is Skyline Pharmaceuticals, Inc.'s most recent federal award?

Skyline Pharmaceuticals, Inc.'s most recent federal contract award is Multi line item pharm (36C77024P0386), from Veterans Integrated Service Network 15 (VHA), on September 12, 2024.

On GovTribe

See Skyline Pharmaceuticals, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors